【佳学基因检测】ADRA1A等位基因突变会增加疾病的风险吗?
基因检测的序列名称:
ADRA1A
人体基因序列变化与疾病表征数据库中的基因代码:
148
人体基因序列数据库中国际交流名称全称
adrenoceptor alpha 1A
中国数据库中基因全称:肾上腺素受体1A基因检测报告英文版基因简介
Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1A-adrenergic receptor. Alternative splicing of this gene generates four transcript variants, which encode four different isoforms with distinct C-termini but having similar ligand binding properties. [provided by RefSeq, Jul 2008]
基因突变所影响的基因信息
Alpha-1-肾上腺素受体(alpha-1-ARs)是G蛋白偶联受体超家族的成员。它们激活有丝分裂反应并调节许多细胞的生长和增殖。存在3种alpha-1-AR亚型:alpha-1A,-1B和-1D,它们均通过G蛋白的Gq / 11家族发出信号,不同的亚型显示出不同的激活模式。该基因编码α-1A-肾上腺素能受体。该基因的可变剪接产生四个转录物变体,其编码具有不同的C末端但具有相似的配体结合特性的四个不同的同工型。[由RefSeq提供,2008年7月]
国际国内该碱基因序列的其他英语文字母简称:
ADRA1C, ADRA1L1, ALPHA1AAR
基因解码对该基因序列在细胞核中的染色体所给予的编号:
该基因序列位于人类第8号染色体上。
基因解码对基因序列的正确定位
该基因序列在GRCh37版本中的起始位置坐标为:26605667;结束位置坐标为:26727003。该基因序列在GRCh38版本中的起始位置坐标为:26738113;结束位置坐标为:26870994。正确的基因信息定位是基因检测和对检测结果进行正确解读的关键。
佳学基因解码对该基因的功能分类:国际版
G-protein coupled receptors/GPCRs excl olfactory receptors
基因解码对该基因的功能分类:中文版
G 蛋白偶联受体/GPCR 不包括嗅觉受体
结构与功能基因解码所揭示的该基因在细胞内发挥作用的场所(国际版):
正在通过基因解码技术进行收集、查证并编辑,请关注佳学基因,获得及明更新的人类基因序列变化与疾病表征数据库的更新内容
结构与功能基因解码所揭示的该基因发挥作用的细胞内位置(中文版):
正在通过基因解码技术进行收集、查证并编辑,请关注佳学基因,获得及明更新的人类基因序列变化与疾病表征数据库的更新内容
该基因序列变化后增加的疾病风险(国际版):
Ventricular Remodeling; Cannabis Dependence; cocaine use; Cocaine Abuse; Cocaine Dependence; Diabetes Mellitus, Experimental; Liver Cirrhosis; Unipolar Depression; Major Depressive Disorder; Bipolar Disorder; Schizophrenia
如果该基因突变后,风险可能增加的疾病类型(中文版):
心室重塑;大麻依赖;使用可卡因;可卡因滥用;可卡因依赖;糖尿病实验性的;肝硬化;单极抑郁症;严重抑郁症;躁郁症;精神分裂症
GWAS基因检测所建立的与该基因的疾病关联(国际版):
正在通过基因解码技术进行收集、查证并编辑,请关注佳学基因,获得及明更新的人类基因序列变化与疾病表征数据库的更新内容
GWAS基因检测所解码的该基因突变会增加风险的疾病种类(中文版):
正在通过基因解码技术进行收集、查证并编辑,请关注佳学基因,获得及明更新的人类基因序列变化与疾病表征数据库的更新内容
以该基因做靶点的药物(国际版):
Amphetamine (Protein heterodimerization activity);Midodrine (Protein heterodimerization activity);Citalopram (Protein heterodimerization activity);Ziprasidone (Protein heterodimerization activity);Cabergoline (Protein heterodimerization activity);Dapiprazole (Protein heterodimerization activity);Amitriptyline (Protein heterodimerization activity);Olanzapine (Protein heterodimerization activity);Alfuzosin (Protein heterodimerization activity);Clozapine (Protein heterodimerization activity);Norepinephrine (Protein heterodimerization activity);Mirtazapine (Protein heterodimerization activity);Mirtazapine (Protein heterodimerization activity);Phenylephrine (Protein heterodimerization activity);Phenylpropanolamine (Protein heterodimerization activity);Loxapine (Protein heterodimerization activity);Promazine (Protein heterodimerization activity);Dipivefrin (Protein heterodimerization activity);Droperidol (Protein heterodimerization activity);Prazosin (Protein heterodimerization activity);Imipramine (Protein heterodimerization activity);Chlorpromazine (Protein heterodimerization activity);Chlorpromazine (Protein heterodimerization activity);Nortriptyline (Protein heterodimerization activity);Amoxapine (Protein heterodimerization activity);Amoxapine (Protein heterodimerization activity);Clonidine (Protein heterodimerization activity);Doxazosin (Protein heterodimerization activity);Labetalol (Protein heterodimerization activity);Metaraminol (Protein heterodimerization activity);Nicardipine (Protein heterodimerization activity);Trazodone (Protein heterodimerization activity);Epinephrine (Protein heterodimerization activity);Thioridazine (Protein heterodimerization activity);Phentolamine (Protein heterodimerization activity);Ergotamine (Protein heterodimerization activity);Nicergoline (Protein heterodimerization activity);Tamsulosin (Protein heterodimerization activity);Methoxamine (Protein heterodimerization activity);Trimipramine (Protein heterodimerization activity);Risperidone (Protein heterodimerization activity);Epinastine (Protein heterodimerization activity);Propiomazine (Protein heterodimerization activity);Tolazoline (Protein heterodimerization activity);Fenoldopam (Protein heterodimerization activity);Trifluoperazine (Protein heterodimerization activity);Pseudoephedrine (Protein heterodimerization activity);Benzphetamine (Protein heterodimerization activity);Flupentixol (Protein heterodimerization activity);Phenoxybenzamine (Protein heterodimerization activity);Maprotiline (Protein heterodimerization activity);Oxymetazoline (Protein heterodimerization activity);Apraclonidine (Protein heterodimerization activity);Ergoloid mesylate (Protein heterodimerization activity);Promethazine (Protein heterodimerization activity);Carvedilol (Protein heterodimerization activity);Doxepin (Protein heterodimerization activity);Nefazodone (Protein heterodimerization activity);Desipramine (Protein heterodimerization activity);Terazosin (Protein heterodimerization activity);Escitalopram (Protein heterodimerization activity);Pergolide (Protein heterodimerization activity);Bromocriptine (Protein heterodimerization activity);Quetiapine (Protein heterodimerization activity);Aripiprazole (Protein heterodimerization activity);Ergonovine (Protein heterodimerization activity);Paliperidone (Protein heterodimerization activity);Bevantolol (Protein heterodimerization activity);Ephedrine (Protein heterodimerization activity);Mephentermine (Protein heterodimerization activity);Methotrimeprazine (Protein heterodimerization activity);4-Methoxyamphetamine (Protein heterodimerization activity);Dextroamphetamine (Protein heterodimerization activity);Phendimetrazine (Protein heterodimerization activity);Acepromazine (Protein heterodimerization activity);Thioproperazine (Protein heterodimerization activity);Zuclopenthixol (Protein heterodimerization activity);Dronedarone (Protein heterodimerization activity);Iloperidone (Protein heterodimerization activity);R450 (Protein heterodimerization activity);Epicept NP-1 (Protein heterodimerization activity);Sertindole (Protein heterodimerization activity);Mianserin (Protein heterodimerization activity);Silodosin (Protein heterodimerization activity);Asenapine (Protein heterodimerization activity);Droxidopa (Protein heterodimerization activity);Xylometazoline (Protein heterodimerization activity);Isometheptene (Protein heterodimerization activity);Levonordefrin (Protein heterodimerization activity);Naphazoline (Protein heterodimerization activity);Tetryzoline (Protein heterodimerization activity);Cirazoline (Protein heterodimerization activity)
针对该基因所产生的突变,可能有正确效果的药物(中文版):
苯丙胺(蛋白质异二聚活性);米多君(蛋白质异二聚活性);西酞普兰(蛋白质异二聚活性);齐拉西酮(蛋白质异二聚活性);卡麦角林(蛋白质异二聚活性);达哌唑(蛋白质异二聚活性);阿米替林(蛋白质异二聚活性);奥氮平(蛋白质异二聚活性);阿夫唑嗪(蛋白质异二聚活性);氯氮平(蛋白质异二聚活性);去甲肾上腺素(蛋白质异二聚活性);米氮平(蛋白质异二聚活性);米氮平(蛋白质异二聚活性);苯肾上腺素(蛋白质异二聚活性);苯丙醇胺(蛋白质异二聚活性);洛沙平(蛋白质异二聚活性);异丙嗪(蛋白质异二聚活性);地匹福林(蛋白质异二聚活性);氟哌利多(蛋白质异二聚活性);哌唑嗪(蛋白质异二聚活性);丙咪嗪(蛋白质异二聚活性);氯丙嗪(蛋白质异二聚活性)异二聚活性);氯丙嗪(蛋白质异二聚活性);去甲替林(蛋白质异二聚活性);阿莫沙平(蛋白质异二聚活性);阿莫沙平(蛋白质异二聚活性);可乐定(蛋白质异二聚活性);多沙唑嗪(蛋白质异二聚活性);拉贝洛尔(蛋白质异二聚活性)活性);间羟胺(蛋白质异二聚活性);尼卡地平(蛋白质异二聚活性);曲唑酮(蛋白质异二聚活性);肾上腺素(蛋白质异二聚活性);硫利达嗪(蛋白质异二聚活性);酚妥拉明(蛋白质异二聚活性);麦角胺(蛋白质异二聚活性) );尼麦角林(蛋白质异二聚活性);坦索罗辛(蛋白质异二聚活性);甲氧明(蛋白质异二聚活性);曲米帕明(蛋白质异二聚活性);利培酮(蛋白质异二聚活性);依匹斯汀(蛋白质异二聚活性);丙哌嗪(蛋白质异二聚活性) ;托拉唑啉(蛋白质异二聚活性);非诺多泮(蛋白质异二聚活性);三氟拉嗪(蛋白质异二聚活性);伪麻黄碱(蛋白质异二聚活性);苯丙胺(蛋白质异二聚活性);氟哌噻吨(蛋白质异二聚活性);苯氧苄胺(蛋白质异二聚活性);马普替林(蛋白质异二聚化活性);羟甲唑啉(蛋白质异二聚化活性);安可乐定(蛋白质异二聚化活性);麦角林甲磺酸盐(蛋白质异二聚化活性);异丙嗪(蛋白质异二聚化活性);卡维地洛(蛋白质异二聚化活性);多虑平(蛋白质异二聚化活性);奈法唑酮(蛋白质异二聚活性);地昔帕明(蛋白质异二聚活性);特拉唑嗪(蛋白质异二聚活性);艾司西酞普兰(蛋白质异二聚活性);培高利特(蛋白质异二聚活性);溴隐亭(蛋白质异二聚活性);喹硫平(蛋白质异二聚活性);阿立哌唑(蛋白质异二聚活性);麦角新碱(蛋白质异二聚活性);帕利哌酮(蛋白质异二聚活性);贝伐洛尔(蛋白质异二聚活性);麻黄碱(蛋白质异二聚活性);美芬特明(蛋白质异二聚活性);甲氧美拉嗪(蛋白质异二聚活性);4-甲氧苯丙胺(蛋白质异二聚活性);右旋苯丙胺(蛋白质异二聚活性);苯二甲曲嗪(蛋白质异二聚活性);乙酰丙嗪(蛋白质异二聚活性);硫丙哌嗪(蛋白质异二聚活性);珠氯噻醇(蛋白质异二聚活性);决奈达隆(蛋白质异二聚活性);伊潘立酮(蛋白质异二聚活性);R450(蛋白质异二聚活性);Epicept NP-1(蛋白质异二聚活性);Sertindole(蛋白质异二聚活性);米安色林(蛋白质异二聚活性);西洛多辛(蛋白质异二聚活性);阿塞那平(蛋白质异二聚活性) ;屈昔多巴(蛋白质异二聚化活性);赛洛唑啉(蛋白质异二聚化活性);异美汀(蛋白质异二聚化活性);左旋诺德福林(蛋白质异二聚化活性);萘甲唑啉(蛋白质异二聚化活性);Tetryzoline(蛋白质异二聚化活性);西拉唑啉(蛋白质异二聚化活性)